Background & aims: Ornithine alphaketoglutarate (OKG) is known for its anabolic and
Introduction
L-ornithine alphaketoglutarate (OKG) is a nutritional supplement applied in both chronically 255, 256 and acutely malnourished patients. [257] [258] [259] [260] [261] Apart from improving nutritional status, OKG supplementation has been suggested to stimulate immune function and to promote wound healing and tissue repair. [258] [259] [260] 262 Multiple studies have addressed the effect of OKG supplementation on protein metabolism in patients following burns, [257] [258] [259] [260] trauma 261 and surgery. 85, 86, [265] [266] [267] [268] [269] In most, nitrogen balance studies were performed using 24-h urinary excretion of urea or nitrogen. All studies assessing intravenous OKG supplementation by nitrogen balance analysis reported an increase in nitrogen retention. 86, 259-261, 265, 268, 269 Four studies performed muscle biopsies to assess total ribosome concentration or polyribosome number following OKG supplementation. 85, 86, 263, 264 The number of ribosomes or polyribosomes is considered a proxy of protein synthesis capacity in skeletal muscle. In all studies, the decline in ribosome and polyribosome number seen in control patients was (at least in part) averted by OKG supplementation. Furthermore, OKG supplementation resulted in a less pronounced decline of muscle free glutamine concentrations. 85, 86, 264 Finally, the effects of OKG on nitrogen balance, intramuscular glutamine concentrations and ribosome number were found to be interrelated. 85, 86 . The effect of OKG on protein metabolism in burn and surgery patients can thus be summarized as maintenance of protein synthesis capacity, possibly combined with decreased proteolysis, and resulting in increased nitrogen retention.
The effect of OKG on proteolysis, a characteristic feature of the metabolic response to injury or trauma, 4 can only indirectly be ascertained from the results of the above-mentioned studies. After all, nitrogen intake, protein synthesis and proteolysis combined are all represented in nitrogen balance measurements. Proteolysis can be studied separately using stable isotopes studies. For these reasons, we chose to study the effect of OKG supplementation on urea production rate, urea being the final common pathway of amino acid breakdown.
Methods a. Study subjects
Sixteen healthy, male volunteers participated in the study. All participants were in good health as determined by medical history, physical examination, analysis of blood cell count, routine blood biochemical profile and urinalysis. 
b. Dietary guidelines
Prior to the study, participants were interviewed at the Department of Nutrition and Dietetics for assessment of dietary intake and physical activity. Dietary guidelines were individually prescribed for a daily protein intake of 1 g/kg·d and aimed at maintaining body weight. Basal metabolic rate (BMR) was estimated using the Harris-Benedict formula 133 and a BMR factor of 1.4 was used to allow for habitual physical activity.
Participants were supplied with Dutch dietary tables 266 and a kitchen scale (Terraillon, Versailles, France). They were instructed to adhere to the dietary instructions and to note and weigh dietary intake for the duration of the diet. Foodstuffs could be obtained from the institution's kitchen using vouchers and an especially prepared warm meal was served daily to participants.
c. Experimental design
The experimental protocol involved a total of 7 days, during which participants strictly complied with dietary guidelines. Subjects were randomised by the hospital pharmacy using balanced blocks of four. From days 4 to 6, single daily doses of either 10 g of OKG (Cetornan®, Chiesi SA,
Zoetermeer, the Netherlands) were ingested under supervision. Both supplements were packed in identical containers in a blinded manner.
Subjects were free moving for the duration of the study and were encouraged to maintain their customary levels of physical activity but to refrain from excessive or competitive exercise. During the urea kinetics measurement day (day 4), subjects remained in the hospital for the major part of the day and commonly performed simple deskwork.
d. Measurements
Participants were seen daily for instructions, weight measurements and collection of dietary intake notes. Subjects were weighed on an electronic scale (SECA, Hamburg, Germany) to the nearest 0.1 kg. Height was measured to the nearest 0.1 cm (DGI 250 D stadiometer, Winssen, the Netherlands).
Nitrogen excretion was determined in a total of three 24 hrs-collections, on days 2, 4 and 7. Urine was collected in plastic containers, kept refrigerated for the duration of collection and acidified with 10 mL 6 M HCl upon collection.
Urea kinetics were studied on day 4 following an overnight fast. Experiments started at 08:00 am.
An i.v. needle was inserted into an antecubital vein and samples for background enrichment and plasma urea concentration were drawn. [
13 C]urea (99% isotopic purity; Campro, Veenendaal, the Netherlands), was weighed in 150 mg aliquots by the hospital pharmacy, dissolved in tap water, and administered as an oral dose on t = 0. Particular attention was paid to assure all tracer was ingested. Blood samples for plasma urea enrichments were drawn from the i.v. needle in 15-min intervals for the first 90 minutes and thereafter in 30-min intervals for a total duration of 6 h. Blood samples were collected in dry lithium heparinised tubes, placed on ice and centrifuged at 4 °C (2550 g, 10 min). Plasma was transferred into polyethylene cups and stored at -20 °C. Breath samples were obtained in duplicate by blowing through a plastic straw into a glass test tube on t = 0 and 30 minutes after ingestion of the tracer. After the second breath sample had been obtained, the first dose of OKG or placebo supplement, dissolved in a glass of orange juice was administered. Thereafter, subjects received regular portions of simple, identical meals for the duration of 6 h. Subjects drank 100 mL water per hour.
e. Sample analysis
Total urinary nitrogen was determined using the Berthelot method. 243 Urea concentration was determined enzymatically (Hitachi 747 autoanalyser, Roche, Mannheim, Germany) with a coefficient of variation of 6% (n = 5).
Urea in deproteinised blood samples was derivatised to 2-methoxypyrimidine and the [ 
g. Statistical Analysis
Data were analysed using statistical software (SPSS 11.0, SPSS Inc, Chicago, IL, USA). Values are presented as mean ± standard deviation (SD), unless stated otherwise. For comparisons between groups Student's t test was used. Changes in nitrogen excretion and body weight over time were analysed using multivariate analysis of variance (MANOVA) for repeated measurements.
Differences were considered significant if p < 0.05 (two-tailed).
Results a. Study subjects
Study subject characteristics were not different between groups (Table 1 ). All subjects completed the study. Energy and macronutrient intakes were similar between groups and are presented in Table 1 . Mean (± SD) daily protein intake was 1.03 ± 0.16 g/kg·d. During the course of the study,
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Chapter 7 mean body weight showed a minimal, yet statistically significant decline from 73.8 to 73.5 kg (p < 0.01, multivariate analysis of variance (MANOVA) for repeated measurements).
Supplementation allocation was found to have had no effect on body weight change (p = 0.60, MANOVA for repeated measurements). 
b. Urea rate of appearance and urea pool
There was no difference in urea Ra between OKG and placebo groups (380 ± 86 µmol/kg·h vs. 
c. Nitrogen excretion
One 24-h urine collection of a study participant was lost. This subject (placebo group) was left out of nitrogen excretion analyses. Nitrogen excretion at separate time points did not differ between groups (p = 0.73 for pre-test, p = 0.37 for day 4 and p = 0.91 for day 7 respectively). MANOVA for repeated measurements found no significant differences in nitrogen excretion between OKG and placebo groups, neither in overall values (p = 0.40) nor in development over time (p = 0.53) ( Table   2 ). Individual nitrogen excretion values are presented in Figure 1 .
Additional analysis of urine collections on the first day of supplementation revealed significantly higher nitrogen excretion rates during the first 6 h immediately following ingestion of OKG or placebo as compared to the 18 h hereafter (9.1 ± 2 vs. 6.4 ± 1 mg/kg·h; p < 0.05 and 9.4 ±2 vs.
6.7 ± 1 mg/kg·h; p < 0.001 in the OKG and placebo group, respectively). Control (n = 7) 12.6 ± 1.7 14.3 ± 2.5 12.2 ± 1.3 0.12 OKG (n = 8) 11.9 ± 2.3 12.9 ± 2.0 12.3 ± 1.9 0.63
Nitrogen excretion is expressed as g/d and presented as mean ± standard deviation. OKG denotes ornithine alphaketoglutarate. p-Values denote significance of overall effect of time on nitrogen excretion as assessed by multivariate analysis of variance (MANOVA).
Figure 1
Individual total urinary nitrogen excretion (g.d-1) from three 24-h collections (pretest, day 4 and day 7). OKG treated subjects (n = 8) are depicted by open triangles, subjects receiving placebo (n = 7) by closed circles.
Discussion
In this stable isotope study in healthy male subjects, a single dose of oral OKG did not affect urea production rate differently than an isonitrogenous placebo. Nitrogen excretion rate increased temporarily following OKG and placebo administration.
One previous study assessed the effect of OKG on urea production rate in seven healthy volunteers, albeit without control subjects. Another explanation for the findings of our study is that the beneficial effects of OKG on protein metabolism and nitrogen economy have all been reported in malnourished elderly or in patients suffering from burns or trauma. 85, 257, 273, 274 The effects of OKG may be limited to conditions of metabolic stress, and for this reason may not have been present in our study. Our finding that OKG supplementation did not stimulate nitrogen retention over the course of three days is in accordance with this. Nitrogen excretion increased in the hours immediately following administration of OKG and placebo, indicating simple renal clearance of ingested nitrogen compounds.
Finally, subjects in our study were responsible for their own dietary intake. Despite individual instruction, especially prepared study meals and free provision of foodstuffs, adherence to the dietary guidelines varied between individuals. Especially caloric intake showed variances between individuals, as the main focus of the diet was a restricted and stable protein intake. On the whole, caloric intake did not completely match prescribed levels and mean body weight showed a minimal, yet statistically significant decline during the course of the study. The effect of a daily and individually varying caloric intake may have obscured possible effects of OKG supplementation on protein metabolism. However, we found this effect to be independent of supplementation group.
In conclusion, following oral supplementation of OKG, no immediate effect on urea production rate in healthy male study subjects could be demonstrated. Also, OKG supplementation did not increase nitrogen retention, as both OKG and placebo administration resulted in a temporary increase in nitrogen excretion. The previously reported positive effect on nitrogen economy and anticatabolic effect of OKG supplementation may only be present in critically ill patients or following a prolonged period of supplementation.
